文献速递骨质疏松与钙磷/甲状旁腺

甲状旁腺癌与非典型甲状旁腺肿瘤中的胚系与体细胞FLCN失活变异

Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

研究对17例「散发性」甲状旁腺癌(PC)和3例非典型甲状旁腺肿瘤(APT)患者进行胚系DNA分析,并对14例PC和2例APT的肿瘤组织测序,另分析74例散发性甲状旁腺腺瘤的FLCN变异。在3例无CDC73或MEN1致病性变异的PC患者中发现胚系FLCN变异,其中2例为已报道的Birt-Hogg-Dubé(BHD)综合征移码变异,1例为意义未定的错义变异c.124G>C(p.G42R);3例均伴肾囊肿,2例伴肺囊肿。16例PC/APT肿瘤中2例(含1例APT)检出体细胞FLCN变异,74例腺瘤中未检出。结论认为FLCN变异与PC的关联可能为该恶性肿瘤的治疗开发提供基础。

要点

  • 在3例无CDC73或MEN1变异的甲状旁腺癌患者中检出胚系FLCN变异。
  • 3例胚系FLCN变异患者均伴肾囊肿,其中2例伴肺囊肿。
  • 16例PC/APT肿瘤中2例检出体细胞FLCN变异,74例散发性腺瘤中未检出。

核心结论

  • FLCN变异与甲状旁腺癌的关联可能为该恶性肿瘤的治疗开发提供基础。

研究设计与样本

  • 分析17例「散发性」甲状旁腺癌(PC)和3例非典型甲状旁腺肿瘤(APT)患者的胚系DNA,这些患者均无胚系CDC73或MEN1致病性变异。
  • 对14例PC和2例APT的可用肿瘤组织进行测序,其中包括2例无可用胚系DNA的患者。
  • 另对74例散发性甲状旁腺腺瘤进行FLCN变异分析。

主要发现

  • 在3例无亲缘关系的PC患者中鉴定出胚系FLCN变异,其中2个移码变异已在Birt-Hogg-Dubé(BHD)综合征患者中描述,错义变异c.124G>C(p.G42R)的致病性尚未明确确立。
  • 错义变异的功能分析显示对翻译后修饰有潜在影响。
  • 3例胚系FLCN变异患者均发现肾囊肿,2例有肺囊肿,这些特征与BHD综合征相关。
  • 16例PC/APT患者的肿瘤中2例(其中1例为APT)检出体细胞FLCN变异,74例散发性甲状旁腺腺瘤中均未检出。
  • 测序未发现FLCN的二次打击,但在3例检出胚系FLCN变异的患者中2例证实该位点杂合性缺失。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Parathyroid cancer (PC) is a rare endocrine neoplasm with high mortality. While surgery is the treatment for patients with the disease, recurrence rates are high, and patients usually succumb to severe hypercalcemia. There is no effective systemic therapy for the disease. OBJECTIVE: To investigate for novel genes causing parathyroid cancer. METHODS: We analyzed the germline DNA of 17 patients with "sporadic" PC and 3 with atypical parathyroid tumors (APTs) who did not have germline CDC73 or MEN1 pathogenic variants. Sequencing of available tumor tissue from 14 patients with PC and 2 with APT was also performed (including 2 patients with no available germline DNA). In addition, sporadic parathyroid adenomas from 74 patients were analyzed for FLCN variants. RESULTS: We identified germline FLCN variants in 3 unrelated patients with PC. The 2 frameshift variants have been described in patients with Birt-Hogg-Dubé (BHD) syndrome, while the pathogenicity of the missense variant c.124G > C (p.G42R) has not been definitively established. Functional analysis of the missense variant showed a potential effect on posttranslational modification. All 3 patients with germline FLCN variants were noted to have renal cysts and 2 had lung cysts, features associated with BHD syndrome. Somatic FLCN variants were identified in tumors from 2 (1 APT) of 16 patients with PC/APT and in none of the 74 sporadic parathyroid adenomas. No second hits in FLCN were noted on sequencing; however, loss of heterozygosity at the locus was demonstrated in 2 of 3 patients with the identified germline FLCN variant. CONCLUSION: The finding of FLCN variants associated with PC may provide the foundation for the development of therapy for this malignancy.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jha S, Welch J, Tora R, et al. Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors. J Clin Endocrinol Metab. 2023. PMID: 36935552. doi:10.1210/clinem/dgad136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。